New Studies Suggest AVISE Lupus Test Improves Diagnosis of Disease
October 28, 2019
Because lupus is hard to diagnose, many patients don’t get the treatments they need, while others get...
News
Lupus Research Alliance Announces 2019 Distinguished Innovator Awards Aimed at New Lupus Treatments
NEW YORK, October 24 -- The Lupus Research Alliance proudly announces two exceptional recipients of the 2019 Dr. William E....
Lupus Research Alliance Welcomes New Senior Director of Marketing and Communications
NEW YORK, NY. October 16 -- The Lupus Research Alliance (LRA) is pleased to announce that seasoned professional Penny...
Potential New Treatment in Phase III Trial
The Lupus Research Alliance is excited to announce that a potential new medicine for lupus—anifrolumab—reduced disease activity versus placebo...
Peer-to-Peer Involvement Advances Scientific Exploration
Many dynamics of lupus contribute to the fact that its complexities have eluded the scientific community—but new hope may...
Epilepsy in People with Lupus
October 17, 2019
A new study published in the European Journal of Neurology showed that epilepsy is significantly more common...
High Levels of Interferon-Alpha Identifies Lupus Patients At Risk for Relapse
October 7, 2019
A new study published in Annals of the Rheumatic Diseases found that among people with lupus, high...
Why Don’t Half of People with Lupus Take Hydroxychlorine As Prescribed?
October 3, 2019
Hydroxychlorine is one of the most common treatments for lupus. But a new study published in The...
LRA Pleased to Share News of Lupus Nephritis Clinical Trial Launch
October 1, 2019
The Lupus Research Alliance is pleased to share news about the launch of EQUALISE, a Phase 1b...
Nearly One-third of People with Lupus Treat Their Pain with Opioids
September 26, 2019
In a newly published Michigan study, nearly 1 in 3 adults with systemic lupus erythematosus used prescription...
Accelerating Medicines Partnership Completes Key Phase
September 24, 2019
The Accelerating Medicines Partnership (AMP) RA/Lupus Program, a joint effort involving the National Institutes of Health (NIH),...
Low-Dose Interleukin-2 Might be Effective for Lupus
September 24, 2019
Interleukin-2 at a low-dose may be effective in treating lupus, according to newly published results of a...